Yes, meloxicam is an NSAID (nonsteroidal anti-inflammatory drug). It belongs to a specific subclass called oxicam NSAIDs and is available only by prescription, unlike over-the-counter options such as ibuprofen or naproxen. Meloxicam is primarily used to treat arthritis-related pain and inflammation.
How Meloxicam Works
Like all NSAIDs, meloxicam reduces pain and inflammation by blocking enzymes called COX-1 and COX-2. These enzymes produce prostaglandins, chemicals your body makes that trigger inflammation, swelling, and pain signaling. What sets meloxicam apart is its selectivity: it inhibits COX-2 about ten times more than COX-1 in laboratory testing. COX-2 is the enzyme most responsible for inflammation and pain, while COX-1 plays a bigger role in protecting your stomach lining and supporting kidney function. This preferential targeting is the reason meloxicam tends to cause fewer stomach-related side effects than older, less selective NSAIDs.
What Meloxicam Is Prescribed For
Meloxicam is FDA-approved for three conditions: osteoarthritis, rheumatoid arthritis, and juvenile rheumatoid arthritis in children aged 2 and older. It is not typically prescribed for short-term pain like headaches or muscle strains, where over-the-counter NSAIDs are usually the first choice. Its strength is in managing ongoing, chronic joint inflammation.
How It Compares to OTC NSAIDs
The biggest practical difference between meloxicam and common over-the-counter NSAIDs is dosing frequency. Meloxicam has a long elimination half-life of 15 to 20 hours, which means you take it just once a day. Ibuprofen, by contrast, needs to be taken every 4 to 6 hours to maintain its effect. Naproxen is closer, dosed twice daily, but still requires more frequent dosing than meloxicam.
In terms of effectiveness, a double-blind clinical trial comparing meloxicam 7.5 mg once daily to naproxen 750 mg daily in rheumatoid arthritis patients found no significant difference in the main measures of pain relief and joint tenderness. Meloxicam did show a significantly lower incidence of gastrointestinal and kidney-related side effects, which makes it an appealing option for people who need long-term anti-inflammatory treatment.
Because meloxicam requires a prescription, your provider has already evaluated whether it’s appropriate for your situation. Over-the-counter NSAIDs don’t come with that built-in screening step, which is worth keeping in mind if you’re comparing the two.
Typical Dosing
For osteoarthritis, the usual starting dose is 5 to 7.5 mg once daily, with a maximum of 10 to 15 mg depending on the formulation. For rheumatoid arthritis, the starting dose is typically 7.5 mg once daily, up to a maximum of 15 mg. Meloxicam reaches its peak blood concentration about 4 to 5 hours after you take it on an empty stomach, or 5 to 6 hours with a high-fat meal. Because of its long half-life, it takes a few days of consistent dosing to reach a steady level in your system, so you may not feel its full benefit on the first day.
Risks Shared With Other NSAIDs
Meloxicam carries the same FDA black box warning that applies to all prescription NSAIDs. This warning covers two categories of serious risk.
The first is cardiovascular. NSAIDs increase the risk of heart attack and stroke, and this risk can appear early in treatment and grow with longer use. Meloxicam is specifically contraindicated for anyone recovering from coronary artery bypass graft surgery.
The second is gastrointestinal. NSAIDs can cause bleeding, ulcers, and perforation anywhere in the stomach or intestines. These events can happen without warning symptoms at any point during treatment. Older adults and anyone with a history of stomach ulcers or GI bleeding face higher risk. While meloxicam’s COX-2 selectivity offers some stomach protection compared to less selective NSAIDs, it does not eliminate this risk entirely.
Who Should Not Take Meloxicam
Meloxicam is contraindicated if you’ve ever had an allergic reaction to it or to any of its inactive ingredients. It’s also off-limits if you’ve experienced asthma, hives, or other allergic reactions after taking aspirin or any other NSAID. Cross-reactivity between NSAIDs is well established, and severe anaphylactic reactions have been reported in people with this history. As noted above, it cannot be used around the time of coronary artery bypass graft surgery due to elevated cardiovascular risk in that specific setting.